VOLUME

THE INCIDENCE OF PHLEBITIS IN PATIENTS RECEIVING AMIODARONE ADMINISTRATION

FEBRUARY 2017 - VOL.13 | ORIGINAL ARTICLE

PDF

Norton L, Ottoboni LK, Varady A, et al. Phlebitis in amiodarone administration: incidence, contributing factors, and clinical implications. Am J Crit Care 2013;22(6):498-505.
Spiering M. Peripheral amiodarone related phlebitis: an institutional nursing guideline to reducepatient harm. J Infus Nurs 2014.37(6):453-460.
Slim AM,Roth JE, Duffy B, et al. The incidence of phlebitis with intravenous amiodarone at guideline dose recommendation. Mil Med 2007;172(12):1279-83.
Ratana J, Kaewnum P, Sealim S, et al. The mechanism affecting the incidence of phlebitis from the use of IV Amiodarone.2014. (Accessed February 15, 2015 at http://drug.pharmacy.psu.ac.th/Question.asp?ID=7758&gid=1)
Ravin W, Phipatanpanit P. Decreased incidence of phlebitis from Amiodarone and Vasopressor. 2008:1Quality Conference 15 Ramathibadi hospital.
Higginson R, Parry A. Phlebitis: treatment, care and prevention. Nurs Times 2011;107(36):18-21.
anchaivijit S. Infection in hospital (3rd edition). Bangkok:Journals and publications Section, Department of Medical Education Technology, Faculty of Medicine, Siriraj Hospital,Mahidol University; 2001.
Medical nursing section, Maharaj Nakorn Chiang Mai Hospital, Faculty of Medicine, Chiang Mai University.

Phlebitis. 2011. (Accessed February 15, 2015 at http://www.med.cmu.ac.th/hospital/nintmed/2012/interestingarticle/85-phlebitis-article.html).

SEARCH VOLUME & NUMBER

RECENT VOLUME & NUMBER